Biomedicines · 2021 · 19 citations · 18 references
Life SciencesImmunologyInfectious DiseasesClinical ImmunologyImmunology Of Infectious DiseasesImmunotherapyCell-mediated ImmunityCytotoxic T Lymphocyte ResponsesImmune Checkpoint RegulationImmune CheckpointsT Cell ActivationT Cell BiologyCytotoxic T Lymphocyte - Associated Protein 4 PathwayCytotoxic T-lymphocyte Antigen 4 SignalingCytotoxic T-lymphocyte-associated Protein 4 InhibitorsCytotoxic T-lymphocyte-associated Protein 4 PathwayCytotoxic T-lymphocyte-associated Protein 4 RegulationT Cell Activation CheckpointsT Cell Immunoglobulin And Mucin-domain Containing-3 RegulationT-cell Mucin Domain-containing Protein 3
Controlling latent tuberculosis infection (LTBI) is important for preventing tuberculosis (TB). However, the immune regulation of LTBI remains uncertain. Immune checkpoints and CD14+ monocytes are pivotal for immune defense but have been scarcely studied in LTBI. We prospectively enrolled participants with LTBI and controls from January 2017 to December 2019. We measured their CD14+ monocytes and the expression of immune checkpoints, including programmed death-1 (PD-1), cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), and T cell immunoglobulin mucin domain-containing-3 (TIM3) on T lymphocytes in peripheral blood mononuclear cells before and after LTBI treatment. A total of 87 subjects were enrolled, including 29 IGRA-negative healthy controls (HC), 58 in the LTBI group (19 without chronic kidney disease (non-CKD), and 39 with end-stage renal disease (ESRD)). All PD-1, CTLA-4, and TIM3 on lymphocytes and monocytes were higher in the LTBI group than that in the HC group. Total CD14+ monocytes were higher and PD-L2+CD14+ over monocytes were lower in patients with LTBI-non-CKD than that in the HC group. After LTBI treatment, CD14+ monocytes, TIM3+ on CD4+ and monocytes, and CTLA-4 on lymphocytes decreased significantly. Multivariable logistic regression indicated that CD14+ monocytes was an independent factor for LTBI-non-CKD from the HC group, whereas PD-L2+CD14+ monocytes and TIM3+ monocytes were significant for LTBI-ESRD from the HC group. In conclusion, LTBI status was associated with increasing CD14+ monocytes plus low PD-L2 expression. By contrast, increased expression of immune checkpoints over all immune cells might be due to Mycobacterium tuberculosis related immune exhaustion, which decreased after treatment.
18
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert · Nature Communications · 2020 · 1.6K citations · Full text
Life Sciences, Immunology, Oncology +17
Tim3 binding to galectin-9 stimulates antimicrobial immunity
Pushpa Jayaraman, Isabel Sada‐Ovalle, Sarah Beladi et al. · The Journal of Experimental Medicine · 2010 · 198 citations · Full text
Amar Singh, Anant Mohan, Aparajit B. Dey et al. · The Journal of Infectious Diseases · 2013 · 139 citations · Full text